Market revenue in 2023 | USD 213.9 million |
Market revenue in 2030 | USD 366.8 million |
Growth rate | 8% (CAGR from 2023 to 2030) |
Largest segment | Services |
Fastest growing segment | Services |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Services, Data Sets |
Key market players worldwide | IQVIA Holdings Inc, International Business Machines Corp, Thermo Fisher Scientific Inc, PAREXEL, PerkinElmer, Icon PLC, Oracle Corp, Syneos Health, Medpace Holdings Inc |
Services was the largest segment with a revenue share of 57.64% in 2023. Horizon Databook has segmented the Canada real world evidence solutions market based on services, data sets covering the revenue growth of each sub-segment from 2018 to 2030.
The increasing demand for RWE & RWD to augment drug discovery & development, rising inclination of regulatory bodies toward the use of RWE, and growing investments by biopharmaceutical companies in R&D are key factors driving the RWE solution market in Canada.
Moreover, strategic initiatives by key players, such as collaborations, acquisitions, and partnerships with emerging players also contribute to market growth. For instance, in June 2022, Dacima Software, a Canadian software company, and EVIDENTIQ, have joined forces to provide an end-to-end software solution for clinical trials.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account